Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Melo, Adriana
NCT05492123: Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer	Recruiting	2	112	RoW	Nivolumab 40 mg in 4 ml Injection, Opdivo, Ipilimumab 200 MG in 40 ML Injection, Yervoy, Chemoradiation, Cisplatin-based chemoradiation	Hospital Israelita Albert Einstein, Bristol-Myers Squibb, Brava	Uterine Cervical Neoplasms	12/26	03/28
Magalhaes, Fernando H
No trials found
NÓBREGA, DANÚBIA RM
No trials found